{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:08:22Z","timestamp":1788898102261,"version":"build-2803163510"},"reference-count":79,"publisher":"European Respiratory Society (ERS)","issue":"166","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are progressive diseases that can lead to right heart failure and death. Right ventricular dysfunction, hypertrophy and maladaptive remodelling are consequences of increased right ventricular (RV) afterload in PAH and CTEPH and are indicative of long-term outcomes. Because RV failure is the main cause of morbidity and mortality in PAH and CTEPH, successful treatments should lead to improvements in RV parameters. Riociguat is a soluble guanylate cyclase stimulator approved for the treatment of PAH and inoperable or persistent\/recurrent CTEPH after pulmonary endarterectomy. This review examines the current evidence showing the effect of riociguat on the right ventricle, with particular focus on remodelling, function and structural parameters in preclinical models and patients with PAH or CTEPH.<\/jats:p>","DOI":"10.1183\/16000617.0061-2022","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T08:20:16Z","timestamp":1664958016000},"page":"220061","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension"],"prefix":"10.1183","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6236","authenticated-orcid":false,"given":"Raymond L.","family":"Benza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Hemnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-758X","authenticated-orcid":false,"given":"Anton","family":"Vonk Noordegraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenappan","family":"Thenappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3540-4983","authenticated-orcid":false,"given":"Carmine D.","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"2024102404065269000_31.166.220061.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.027"},{"key":"2024102404065269000_31.166.220061.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01900-2018"},{"key":"2024102404065269000_31.166.220061.3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0112-2016"},{"key":"2024102404065269000_31.166.220061.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.047"},{"key":"2024102404065269000_31.166.220061.5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/cvr\/cvx160","article-title":"The overloaded right heart and ventricular interdependence","volume":"113","author":"Naeije","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2024102404065269000_31.166.220061.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029254"},{"key":"2024102404065269000_31.166.220061.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.911818"},{"key":"2024102404065269000_31.166.220061.8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2016.12.099","article-title":"Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension","volume":"230","author":"Ghio","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.898122"},{"key":"2024102404065269000_31.166.220061.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.068"},{"key":"2024102404065269000_31.166.220061.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft044"},{"key":"2024102404065269000_31.166.220061.12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00380-018-1168-7","article-title":"Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension","volume":"33","author":"Kamimura","year":"2018","journal-title":"Heart Vessels"},{"key":"2024102404065269000_31.166.220061.13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcmg.2020.08.017","article-title":"Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension","volume":"14","author":"Badagliacca","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024102404065269000_31.166.220061.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01744-8"},{"key":"2024102404065269000_31.166.220061.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl477"},{"key":"2024102404065269000_31.166.220061.16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12931-018-0913-x","article-title":"Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study","volume":"19","author":"Fischer","year":"2018","journal-title":"Respir Res"},{"key":"2024102404065269000_31.166.220061.17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00059-013-3842-y","article-title":"Right ventricular longitudinal deformation parameters and exercise capacity: prognosis of patients with chronic thromboembolic pulmonary hypertension","volume":"39","author":"Sunbul","year":"2014","journal-title":"Herz"},{"key":"2024102404065269000_31.166.220061.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.655266"},{"key":"2024102404065269000_31.166.220061.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.08.022"},{"key":"2024102404065269000_31.166.220061.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330403"},{"key":"2024102404065269000_31.166.220061.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0904473"},{"key":"2024102404065269000_31.166.220061.22","unstructured":"Bayer AG . Adempas: US Prescribing Information 2018. http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Adempas_PI.pdf Date last accessed: September 2020."},{"key":"2024102404065269000_31.166.220061.23","unstructured":"Bayer AG . Adempas (Riociguat Tablets): EU Summary of Product Characteristics 2019. www.ema.europa.eu\/en\/documents\/product-information\/adempas-epar-product-information_en.pdf Date last accessed: September 2020."},{"key":"2024102404065269000_31.166.220061.24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.chest.2016.05.024","article-title":"Riociguat: mode of action and clinical development in pulmonary hypertension","volume":"151","author":"Ghofrani","year":"2017","journal-title":"Chest"},{"key":"2024102404065269000_31.166.220061.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105914"},{"key":"2024102404065269000_31.166.220061.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209657"},{"key":"2024102404065269000_31.166.220061.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209655"},{"key":"2024102404065269000_31.166.220061.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00114407"},{"key":"2024102404065269000_31.166.220061.29","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1186\/1471-2210-11-S1-O9","article-title":"Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis","volume":"11","author":"Evgenov","year":"2011","journal-title":"BMC Pharmacol"},{"key":"2024102404065269000_31.166.220061.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043433"},{"key":"2024102404065269000_31.166.220061.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-2037OC"},{"key":"2024102404065269000_31.166.220061.32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2016.04.098","article-title":"Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice","volume":"216","author":"Pradhan","year":"2016","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.33","first-page":"3293584","article-title":"Effect of riociguat and sildenafil on right heart remodeling and function in pressure overload induced model of pulmonary arterial banding","volume":"2018","author":"Rai","year":"2018","journal-title":"Biomed Res Int"},{"key":"2024102404065269000_31.166.220061.34","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00245.2007"},{"key":"2024102404065269000_31.166.220061.35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2015.05.105","article-title":"Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"195","author":"Marra","year":"2015","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12931-018-0957-y","article-title":"Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)","volume":"19","author":"Marra","year":"2018","journal-title":"Respir Res"},{"key":"2024102404065269000_31.166.220061.37","doi-asserted-by":"crossref","first-page":"2045893217746111","DOI":"10.1177\/2045893217746111","article-title":"Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension","volume":"8","author":"Murata","year":"2018","journal-title":"Pulm Circ"},{"key":"2024102404065269000_31.166.220061.38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000510860","article-title":"Clinical significance of guanylate cyclase stimulator, riociguat, on right ventricular functional improvement in patients with pulmonary hypertension","volume":"146","author":"Murata","year":"2021","journal-title":"Cardiology"},{"key":"2024102404065269000_31.166.220061.39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.healun.2021.06.020","article-title":"Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"40","author":"Benza","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.40","first-page":"100579","article-title":"Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - a randomized controlled study","volume":"29","author":"Aoki","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2024102404065269000_31.166.220061.41","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.healun.2018.01.368","article-title":"Switching from PDE5i to riociguat in the RESPITE study: effect on right heart function","volume":"37","author":"Benza","year":"2018","journal-title":"J Heart Lung Translant"},{"key":"2024102404065269000_31.166.220061.42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2018.07.015","article-title":"Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics","volume":"269","author":"Darocha","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.43","doi-asserted-by":"crossref","first-page":"1753466621995048","DOI":"10.1177\/1753466621995048","article-title":"Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension","volume":"15","author":"Momoi","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"2024102404065269000_31.166.220061.44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cjca.2018.06.007","article-title":"Effects of riociguat on right ventricular remodelling in chronic thromboembolic pulmonary hypertension patients: a prospective study","volume":"34","author":"Ahmadi","year":"2018","journal-title":"Can J Cardiol"},{"key":"2024102404065269000_31.166.220061.45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00408-018-0160-4","article-title":"Initial riociguat monotherapy and transition from sildenafil to riociguat in patients with idiopathic pulmonary arterial hypertension: influence on right heart remodeling and right ventricular-pulmonary arterial coupling","volume":"196","author":"Taran","year":"2018","journal-title":"Lung"},{"key":"2024102404065269000_31.166.220061.46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.healun.2016.12.012","article-title":"Comparison of hemodynamic parameters in treatment-na\u00efve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study","volume":"36","author":"Gali\u00e8","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.47","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309621"},{"key":"2024102404065269000_31.166.220061.48","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02425-2016"},{"key":"2024102404065269000_31.166.220061.49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2020.05.044","article-title":"Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE","volume":"317","author":"Benza","year":"2020","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.50","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fphar.2018.01550","article-title":"Acute iloprost inhalation improves right ventricle function in pulmonary artery hypertension: a cardiac magnetic resonance study","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024102404065269000_31.166.220061.51","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.amjcard.2013.08.003","article-title":"Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study)","volume":"112","author":"Cha","year":"2013","journal-title":"Am J Cardiol"},{"key":"2024102404065269000_31.166.220061.52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcu.22396","article-title":"A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: results from a multicenter, prospective, cohort study","volume":"45","author":"Kim","year":"2017","journal-title":"J Clin Ultrasound"},{"key":"2024102404065269000_31.166.220061.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00121-9"},{"key":"2024102404065269000_31.166.220061.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200410-1411OC"},{"key":"2024102404065269000_31.166.220061.55","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1263"},{"key":"2024102404065269000_31.166.220061.56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14779072.2020.1807942","article-title":"Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension","volume":"18","author":"Zhao","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024102404065269000_31.166.220061.57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.healun.2017.08.009","article-title":"Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension","volume":"37","author":"Badagliacca","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.58","doi-asserted-by":"crossref","first-page":"2045893217748307","DOI":"10.1177\/2045893217748307","article-title":"The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study","volume":"8","author":"Sato","year":"2018","journal-title":"Pulm Circ"},{"key":"2024102404065269000_31.166.220061.59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.chest.2019.09.009","article-title":"Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension","volume":"157","author":"D'Alto","year":"2020","journal-title":"Chest"},{"key":"2024102404065269000_31.166.220061.60","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/clc.22197","article-title":"Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension","volume":"36","author":"Surie","year":"2013","journal-title":"Clin Cardiol"},{"key":"2024102404065269000_31.166.220061.61","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306851"},{"key":"2024102404065269000_31.166.220061.62","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.acra.2018.04.002","article-title":"MRI-derived regional biventricular function in patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy","volume":"25","author":"Maschke","year":"2018","journal-title":"Acad Radiol"},{"key":"2024102404065269000_31.166.220061.63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jelectrocard.2015.12.006","article-title":"Changes in surface electrocardiogram in patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy. Correlations with hemodynamic and echocardiographic improvements after surgery","volume":"49","author":"Ghio","year":"2016","journal-title":"J Electrocardiol"},{"key":"2024102404065269000_31.166.220061.64","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00330-018-5696-4","article-title":"Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients","volume":"29","author":"Schoenfeld","year":"2019","journal-title":"Eur Radiol"},{"key":"2024102404065269000_31.166.220061.65","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1111\/echo.14503","article-title":"Improvements of right ventricular function and hemodynamics after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"36","author":"Kanar","year":"2019","journal-title":"Echocardiography"},{"key":"2024102404065269000_31.166.220061.66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.healun.2015.08.007","article-title":"Echocardiographic evidence of right ventricular functional improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"35","author":"Broch","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjcard.2014.10.034","article-title":"Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension","volume":"115","author":"Tsugu","year":"2015","journal-title":"Am J Cardiol"},{"key":"2024102404065269000_31.166.220061.68","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.healun.2016.04.006","article-title":"Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension","volume":"35","author":"Badagliacca","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.11.002"},{"key":"2024102404065269000_31.166.220061.70","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2019.09.038","article-title":"Long-term changes of right ventricular myocardial deformation and remodeling studied by cardiac magnetic resonance imaging in patients with chronic thromboembolic pulmonary hypertension following pulmonary thromboendarterectomy","volume":"300","author":"Waziri","year":"2020","journal-title":"Int J Cardiol"},{"key":"2024102404065269000_31.166.220061.71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/icvts\/ivaa088","article-title":"Limitations of right ventricular annular parameters in the early postoperative period following pulmonary endarterectomy: an observational study","volume":"31","author":"R\u00e9zaiguia-Delclaux","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2024102404065269000_31.166.220061.72","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012914"},{"key":"2024102404065269000_31.166.220061.73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2017.09.026","article-title":"Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension","volume":"37","author":"Badagliacca","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024102404065269000_31.166.220061.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.04.005"},{"key":"2024102404065269000_31.166.220061.75","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306142"},{"key":"2024102404065269000_31.166.220061.76","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3390\/jcm10132995","article-title":"Echocardiographic assessment of right ventricular\u2013arterial coupling in predicting prognosis of pulmonary arterial hypertension patients","volume":"10","author":"Kazimierczyk","year":"2021","journal-title":"J Clin Med"},{"key":"2024102404065269000_31.166.220061.77","doi-asserted-by":"crossref","first-page":"604615","DOI":"10.1155\/2010\/604615","article-title":"Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension","volume":"2010","author":"Overbeek","year":"2010","journal-title":"Int J Rheumatol"},{"key":"2024102404065269000_31.166.220061.78","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000426"},{"key":"2024102404065269000_31.166.220061.79","doi-asserted-by":"publisher","DOI":"10.1086\/674884"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0061-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:25Z","timestamp":1740373525000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0061-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":79,"journal-issue":{"issue":"166","published-online":{"date-parts":[[2022,10,5]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1183\/16000617.0061-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0061-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]}}}